Month: July 2012
Alzheimer’s Treatment Shows Promise in Small, 3-Year Trial
Can a Parent’s Job Raise Odds for Birth Defects in Baby?
Drug Widely Used to Treat MS May Not Slow Progression
Study Ties Infant Birth Weight to Mothers’ Breast Cancer Risk
Sodium Buildup in Brain Linked to Disability in MS Patients
Weight-Loss Surgery May Not Cut Medical Costs: Study
TUESDAY, July 17 (HealthDay News) — Although patients do indeed lose weight after bariatric surgery, health-care costs remain about the same as they were before the procedure, according to a new study.
Japan Nuke Disaster Will Kill Up to 1,300 People Worldwide, Study Estimates
TUESDAY, July 17 (HealthDay News) — Radiation from last year’s disaster at Japan’s Fukushima Daiichi nuclear plant may eventually cause up to 1,300 deaths and 2,500 cases of cancer worldwide, according to U.S. researchers who calculated the global health effects of the incident.
Health Highlights: July 17, 2012
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Incontinence Affects Young Childless Women, Too
First Drug Approved to Lower Risk of Acquiring HIV
TUESDAY, July 17 (HealthDay News) — Truvada (emtricitabine/tenofovir disoproxil fumarate) is the first drug to be approved by the U.S. Food and Drug Administration to reduce the risk of contracting HIV among adults at higher risk of acquiring the AIDS-causing virus.
New Drug Approved for Colonoscopy Preparation
TUESDAY, July 17 (HealthDay News) — Prepopik (sodium picosulfate, magnesium oxide and citric acid) has been approved by the U.S. Food and Drug Administration for adults preparing for a colonoscopy, a diagnostic procedure to inspect the colon’s inner lining.